Cellectis S.A.: Form 20-F for the period ended Dec 31, 2019
Filed with the SEC on Mar 5, 2020 and accepted by EDGAR at Mar 4, 2020, 17:47 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2019-01-01 to 2019-12-31 | $15.2m | ifrs-full:Revenue |
| Cost of revenue | 12 months2019-01-01 to 2019-12-31 | $11.4m | ifrs-full:CostOfSales |
| Operating income | 12 months2019-01-01 to 2019-12-31 | −$123.6m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2019-01-01 to 2019-12-31 | $0 | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2019-01-01 to 2019-12-31 | −$102.1m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months2019-01-01 to 2019-12-31 | −$2.41 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2019-01-01 to 2019-12-31 | −$2.41 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2019-01-01 to 2019-12-31 | −$69.1m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2019-01-01 to 2019-12-31 | $12.9m | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2019-12-31 | $340.5m | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2019-12-31 | $391.5m | ifrs-full:CurrentAssets |
| Total assets | At period end2019-12-31 | $467.5m | ifrs-full:Assets |
| Current liabilities | At period end2019-12-31 | $62.6m | ifrs-full:CurrentLiabilities |
| Shareholders' equity | At period end2019-12-31 | $315.1m | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | At period end2019-12-31 | 42,465,669 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001193125-20-061833. Last ingested by Listed: Oct 28, 2026, 06:05 ET. Listed shows no prices and gives no investment advice.